000 01538 a2200409 4500
005 20250512035004.0
264 0 _c19880202
008 198802s 0 0 eng d
022 _a0284-186X
024 7 _a10.3109/02841868709089973
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHrafnkelsson, J
245 0 0 _aTolerance of radiotherapy combined with adjuvant chemotherapy in breast cancer.
_h[electronic resource]
260 _bActa oncologica (Stockholm, Sweden)
_c1987
300 _a269-72 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aAxilla
650 0 4 _aBreast Neoplasms
_xtherapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aMenopause
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aPulmonary Fibrosis
_xetiology
650 0 4 _aRadiotherapy, High-Energy
_xadverse effects
650 0 4 _aRandom Allocation
700 1 _aNilsson, K
700 1 _aSöderberg, M
773 0 _tActa oncologica (Stockholm, Sweden)
_gvol. 26
_gno. 4
_gp. 269-72
856 4 0 _uhttps://doi.org/10.3109/02841868709089973
_zAvailable from publisher's website
999 _c3126557
_d3126557